Umbhali: William Ramirez
Umhla Wokudalwa: 20 Eyomsintsi 2021
Hlaziya Umhla: 20 Eyomqungu 2025
Anonim
Vitamin B7 (Biotin)
Ividiyo: Vitamin B7 (Biotin)

Umxholo

IBiotin yivithamini. Ukutya okufana namaqanda, ubisi, okanye iibhanana ziqulathe inani elincinci le-biotin.

I-Biotin isetyenziselwa ukunqongophala kwe-biotin. Ikwayasetyenziswa ekulahlekelweni ziinwele, iinzipho eziqhekekileyo, kunye nezinye iimeko, kodwa abukho ubungqina obuchanekileyo benzululwazi obuxhasa ezi zinto zisetyenziswayo.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe IBHAYIBHILE zezi zilandelayo:

Kusenokwenzeka ukuba iyasebenza ...

  • Ukusilela kweBiotin. Ukuthatha i-biotin kunokunceda ukunyanga amanqanaba egazi asezantsi e-biotin. Inokuthintela amanqanaba egazi e-biotin ekubeni asezantsi kakhulu. Amanqanaba egazi asezantsi e-biotin anokubangela ukucheba kweenwele kunye nerhashalala ejikeleze amehlo, impumlo kunye nomlomo. Ezinye iimpawu zibandakanya ukudakumba, ukungabikho komdla, ukubona izinto ezingekhoyo, kunye nokubetha ezingalweni nasemilenzeni. Amanqanaba e-biotin asezantsi anokuvela kubantu abakhulelweyo, abanesondlo setyhubhu yexesha elide, abangondlekanga, abaye baphulukana nobunzima ngokukhawuleza, okanye abanelifa elithile. Ukutshaya icuba kunokubangela amanqanaba egazi asezantsi e-biotin.

Kusenokwenzeka ukuba ayisebenzi ...

  • Multiple sclerosis (MS). Idosi ephezulu ye-biotin ayinciphisi ukukhubazeka kubantu abane-MS. Ikwabonakala ngathi ayichaphazeli umngcipheko wokuphinda ubuye.
  • Rough, isikhumba esinamaxolo esikhumbeni nasebusweni (seborrheic dermatitis). Ukuthatha i-biotin kubonakala ngathi akuncedisi ukuphucula ukukhawuleza kwiintsana.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

  • Isimo esizuzwe njengelifa esichaphazela ingqondo kunye nezinye iinxalenye zenkqubo ye-nervous (biotin-thiamine-response-basal ganglia disease). Abantu abanale meko bafumana iziqendu zokutshintsha kwemeko yengqondo kunye neengxaki zemisipha. Uphando lwakwangoko lubonisa ukuba ukuthatha i-biotin nge-thiamine akuyinciphisi iimpawu ngaphezu kokuthatha i-thiamine kuphela. Kodwa indibaniselwano inokunciphisa ixesha elide leziqendu.
  • Iinzipho Brittle. Uphando lwakwangoko lubonisa ukuba ukuthatha i-biotin ngomlomo ukuya kuthi ga kunyaka kungonyusa ubungqingqwa bezinzipho kunye neenzwane zabantu kwizikhonkwane ezinobukrelekrele.
  • Seswekile. Uphando olulinganiselweyo lubonisa ukuba ukuthatha i-biotin akuphuculi amanqanaba eswekile yegazi kubantu abanesifo seswekile.
  • Iintlanzi zemisipha. Abantu abafumana i-dialysis bahlala beba ne-cramp yemisipha. Uphando lwakwangoko lubonisa ukuba ukuthatha i-biotin ngomlomo kunokunciphisa iincampu zemisipha kwaba bantu.
  • Isifo sikaLou Gehrig (amyotrophic lateral sclerosis okanye i-ALS).
  • Uxinzelelo.
  • Intlungu yomntu kubantu abanesifo seswekile (isifo seswekile seswekile).
  • Ukuphulukana neenwele ezitshitshisiweyo (alopecia areata).
  • Ezinye iimeko.
Ubungqina obungakumbi buyafuneka ukukala i-biotin kwezi zinto zisetyenziswayo.

I-Biotin yinto ebalulekileyo ye-enzyme emzimbeni eyaphula izinto ezithile ezinje ngamafutha, ii-carbohydrate, kunye nezinye.

Akukho luvavanyo lulungileyo lwaselebhu lokufumanisa amanqanaba asezantsi e-biotin, ke le meko ihlala ichongwa ngeempawu zayo, ezibandakanya ukucheba kweenwele (rhoqo kunye nelahleko yombala weenwele) kunye nerhashalala elibomvu elijikeleze amehlo, impumlo, nomlomo . Ezinye iimpawu zibandakanya ukudakumba, ukudinwa, nemibono, kunye ukurhawuzelela iingalo nemilenze. Kukho ubungqina bokuba isifo seswekile sinokubangela amanqanaba asezantsi e-biotin.

Xa kuthathwa ngomlomo: Biotin ngu NGOKUKHUSELEKILEYO kubantu abaninzi xa bethathwe ngomlomo ngokufanelekileyo. Iyanyamezeleka xa isetyenziswa kwiidosi ezicetyiswayo.

Xa isetyenziswa eluswini: Biotin ngu NGOKUKHUSELEKILEYO kubantu abaninzi xa besetyenziswa eluswini njengeemveliso zezithambiso eziqulathe ukuya kuthi ga kwi-0.6% ye-biotin.

Xa unikezwe ngokudutyulwa: Biotin ngu UKHUSELEKO OLUNOKWENZEKA xa unikwe njengefoto kwi-muscle.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: Biotin ngu NGOKUKHUSELEKILEYO xa isetyenziswe kwixabiso elinconywayo ngexesha lokukhulelwa kunye nokuncancisa.

Abantwana: Biotin ngu NGOKUKHUSELEKILEYO xa ithathwa ngomlomo kwaye ngokufanelekileyo.

Imeko yelifa apho umzimba ungenakho ukusebenza nge-biotin (ukusilela kwe-biotinidase): Abantu abakule meko banokufuna i-biotin eyongezelelweyo.

Uxilongo lwezintsoAbantu abafumana i-dialysis yezintso banokufuna i-biotin eyongezelelweyo. Jonga umboneleli wakho wezempilo.

UkutshayaAbantu abatshayayo banokuba namanqanaba asezantsi e-biotin kwaye banokufuna isongezelelo se-biotin.

Iimvavanyo zaselebhuUkuthatha izongezo ze-biotin kunokuphazamisa iziphumo zovavanyo lweelebhu ezahlukeneyo. I-Biotin inokubangela ukuphakama okuphezulu ngokuxoka okanye iziphumo zovavanyo eziphantsi. Oku kunokukhokelela kuvavanyo oluphosakeleyo okanye olungachanekanga. Tshela ugqirha wakho ukuba uthatha izongezo ze-biotin, ngakumbi ukuba kuvavanyo lweelebhu lwenziwe njengoko unokufuna ukuyeka ukuthatha i-biotin ngaphambi kovavanyo lwegazi. Uninzi lweevithamini ezininzi zinedosi ephantsi ye-biotin, ekungenakwenzeka ukuba iphazamise uvavanyo lwegazi. Kodwa thetha nogqirha wakho ukuze uqiniseke.

Ayaziwa ukuba le mveliso iyasebenzisana nawaphi na amayeza.

Ngaphambi kokuba uthathe le mveliso, thetha nengcali yezempilo ukuba ngaba uthatha nawaphi na amayeza.
I-alpha-lipoic acid
I-alpha-lipoic acid kunye ne-biotin ethathwe kunye inokunciphisa ukufunxeka komzimba kwenye.
Vitamin B5 (pantothenic acid)
I-Biotin kunye ne-vitamin B5 ethathwe kunye inokuthi inciphise ukufunxeka komzimba kwenye.
Amaqanda amhlophe
Iqanda elimhlophe elimhlophe linokubopha kwi-biotin emathunjini kwaye ligcine lingangeni. Ukutya amaqanda ama-2 okanye ngaphezulu amhlophe angaphekwanga yonke imihla kangangeenyanga ezininzi kubangele ukusilela kwe-biotin enzulu ngokwaneleyo ukuvelisa iimpawu.
La machiza alandelayo afundwe kuphando lwezesayensi:

ABADALA

NGOMLOMO:
  • Ngokubanzi: Akukho sibonelelo sokutya sicetyiswayo (i-RDA) simiselwe i-biotin. Ukufakwa okwaneleyo (AI) kwe-biotin zii-30 mcg zabantu abadala ngaphezulu kweminyaka eyi-18 kunye nabasetyhini abakhulelweyo, kunye ne-35 mcg yabasetyhini abanyisayo.
  • Ukusilela kweBiotinKusetyenziswe i-10 mg yonke imihla.
ABANTWANA

NGOMLOMO:
  • Ngokubanzi: Akukho sibonelelo sokutya sicetyiswayo (i-RDA) simiselwe i-biotin. Inani elaneleyo (i-AI) le-biotin zii-7 mcg kwiintsana ezi-0-12 iinyanga, 8 mcg kubantwana abaneminyaka eyi-1-3, i-12 mcg yabantwana iminyaka emi-4-8, i-20 mcg yabantwana abaneminyaka eli-9 ukuya kweli-13, kunye nama-25 mcg kulutsha 14-18 iminyaka.
  • Ukusilela kweBiotin: Ukufikelela kwi-10 mg yonke imihla isetyenzisiwe kwiintsana.
Biotina, Biotine, Biotine-D, Coenzyme R, D-Biotin, Vitamin B7, Vitamin H, Vitamine B7, Vitamine H, W Factor, Cis-hexahydro-2-oxo-1H-thieno [3,4-d] -imidazole -4-yevalile Acid.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.


  1. ICree BAC, umsiki G, uWolinsky JS, et al. Ukhuseleko kunye nokusebenza kwe-MD1003 (idosi ephezulu ye-biotin) kwizigulana ezine-multiple sclerosis (SPI2) eqhubekekayo: ilingo elingahleliwe, elingaboniyo, elilawulwa yi-placebo, inqanaba lesithathu. ILancet Neurol. 2020.
  2. U-Li D, uFerguson A, uCervinski MA, uLynch KL, uKyle PB. Uxwebhu olukhokelayo lwe-AACC ngoNgenelelo lweBiotin kwiiMvavanyo zeLebhu. J Appl ilebhu yeMed. Ngo-2020; 5: 575-587. Jonga i-abstract.
  3. U-Kodani M, Poe A, Drobeniuc J, Mixson-Hayden T. Ukuchongwa kokuphazamiseka okunokubakho kwe-biotin ekuchanekeni kweziphumo zokuvavanywa kwe-serologic yeempawu ezahlukeneyo zentsholongwane ye-hepatitis. J Med Intsholongwane. Jonga i-abstract.
  4. Branger P, Parienti JJ, Derache N, Kassis N, Assouad R, Maillart E, Defer G. Ukubuyela umva ngexesha lokunyanga okuphezulu kwe-Biotin kwi-Progressive Multiple Sclerosis: I-Case-Crossover kunye nePropension Score-Adjusted Cohort. Neurotherapeutics. 2020. Jonga okungaqondakaliyo.
  5. UTourbah A, uLebrun-Frenay C, uElan G, et al. Ubunzima I-MD1003 (i-High-Dose Biotin) yoNyango lwe-Sclerosis eqhubekayo: Isifundo esilawulwa ngokungaQhelekanga, esingaboni kabini, esilawulwa yiPlacebo. Iscler Scler. Ngo-2016; 22: 1719-1731. Jonga i-abstract.
  6. UJuntas-Morales R, uPageot N, uBendarraz A, et al. Idosi ephezulu yamayeza e-biotin (MD1003) kwi-amyotrophic lateral sclerosis: Isifundo somqhubi. Unyango lwezoNyango. 2020; 19: 100254. Jonga i-abstract.
  7. UDemas A, uCochin JP, uHardy C, uVaschalde Y, uBourre B, uLabauge P.Ukuvuselelwa kwenkqubo yokuQiniseka ngokuPhindaphindwayo kweSclerosis ngexesha lonyango ngeBiotin. Neurol Ther. Ngo-2019; 9: 181-185. Jonga i-abstract.
  8. UCouloume L, uBarbin L, uLeray E, et al. Idosi ephezulu ye-biotin kwi-multiple sclerosis eqhubekayo: Isifundo esiza kubakho kwizigulana ezili-178 kwinkqubo yesiqhelo yeklinikhi. Iscler Scler. Ngo-2019: 1352458519894713. Jonga i-abstract.
  9. I-Elecsys Anti-SARS-CoV-2-IiCobas. IRoche Diagnostics GmbH. Ifumaneka kwi: https://www.fda.gov/media/137605/download.
  10. I-Trambas CM, iSikaris KA, iLu ZX. Isilumkiso ngokubhekisele kunyango lwe-biotin yedosi ephezulu: ukuxilongwa gwenxa kwe-hyperthyroidism kwizigulana ze-euthyroid. NguMed J Aust. Ngo-2016; 205: 192. Jonga i-abstract.
  11. USedel F, uPapeix C, uBellanger A, uTouitou V, uLebrun-Frenay C, uGalanaud D, et al. Iidosi eziphezulu ze-biotin kwisifo esinganyangekiyo esihamba rhoqo kwi-sclerosis: isifundo somqhubi wenqwelo moya. Ngo-2015; 4: 159-69. ikhonkco: 10.1016 / j.msard.2015.01.005.
  12. I-Tabarki B, Alfadhel M, AlShahwan S, Hundallah K, AlShafi S, AlHashem A. Unyango lwesifo se-basal ganglia esiphendulayo se-biotin: isifundo esivulekileyo sokuthelekisa phakathi kokudityaniswa kwe-biotin kunye ne-thiamine kunye ne-thiamine yodwa. I-Eur J Paediatr Neurol. Ngo-2015; 19: 547-52. ikhonkco: 10.1016 / j.ejpn.2015.05.008. Jonga i-abstract.
  13. I-FDA ilumkisa ukuba i-Biotin isenokuphazamisana novavanyo lweLebhu: Unxibelelwano ngoKhuseleko lwe-FDA. https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm586505.htm. Ukuhlaziywa kweyeNkanga 28, 2017. Ifikeleleke ngoNovemba 28, 2017.
  14. IBiscolla RPM, Chiamolera MI, Kanashiro I, Maciel RMB, Vieira JGH. I-10 eyodwa ye-mg Oral Dose ye-Biotin Interferes ngovavanyo lweMisebenzi yeTyroid. Idlala lesikhumba 2017; 27: 1099-1100. Jonga i-abstract.
  15. UPiketty ML, uPrie D, uSedel F, et al. Unyango lwe-biotin yedosi ephezulu ekhokelela kubuchwephesha be-biochemical endocrine profiles: ukuqinisekiswa kwendlela elula yokoyisa ukuphazamiseka kwe-biotin. Iiklinikhi zeLebhu yeLebhu Med 2017; 55: 817-25. Jonga i-abstract.
  16. I-Trambas CM, iSikaris KA, iLu ZX. Okungakumbi kwiZifo zeBiotin zoNyango lokuGweba amangcwaba. N Engl J Med 2016; 375: 1698. Jonga i-abstract.
  17. U-Elston MS, uSehgal S, uDu Toit S, uYarndley T, uConaglen JV. Isifo seNgcaciso yamangcwaba ngenxa yophazamiseko lwe-biotin immunoassay-ityala kunye nokuphononongwa koncwadi. J Ikliniki ye-Endocrinol Metab 2016; 101: 3251-5. Jonga i-abstract.
  18. UKummer S, uHermsen D, uDistelmaier F.Unyango lweBiotin olinganisa isifo seMangcwaba. U-Eng Eng J Med 2016; 375: 704-6. Jonga i-abstract.
  19. I-Barbesino G. Misdiagnosis yesifo seMangcwaba ene-hyperthyroidism ebonakalayo kwisigulana esithatha i-biotin megadoses. Idlala lengqula 2016; 26: 860-3. Jonga i-abstract.
  20. USulaiman RA. Unyango lwe-Biotin olubangela iziphumo ezingalunganga ze-immunoassay: Ilizwi lesilumkiso kwiiklinikhi. Isiyobisi seDrr Ther 2016; 10: 338-9. Jonga i-abstract.
  21. I-Bülow Pedersen I, i-Laurberg P. I-Biochemical Hyperthyroidism kusana olusandul 'ukuzalwa olwenziwe yi-Assay Interaction evela kwi-Biotin Intake. I-thyroid yegazi J 2016; 5: 212-15. Jonga i-abstract.
  22. UMinkovsky A, uLee MN, uDowlatshahi M, et al. Unyango lwe-biotin ephezulu yonyango lwesibini lokuqhubela phambili kwesclerosis inokuphazamisa uvavanyo lwe-thyroid. I-AACE Case Case 2016; 2: e370-e373. Jonga i-abstract.
  23. U-Oguma S, uAndo mna, uHirose T, et al. I-Biotin yonyusa amaqhekeza esihlunu sezigulana ze-hemodialysis: ityala eliza kubakho. UTohoku J Exp Med 2012; 227: 217-23. Jonga i-abstract.
  24. Waghray A, Milas M, Nyalakonda K, Siperstein AE. I-hormone ephantsi yeparathyroid esekwe kukuphazamiseka kwe-biotin: uthotho lwamatyala. Ukuziqhelanisa ne-Endocr 2013; 19: 451-5. Jonga i-abstract.
  25. Kwok JS, Chan IH, Chan MH. Ukuphazamiseka kwe-Biotin kwi-TSH kunye nemilinganiselo yehomoni ye-thyroid yasimahla. Izifo. Ngo-2012; 44: 278-80. Jonga i-abstract.
  26. UVadlapudi AD, uVadlapatla RK, uMitra AK. Umthuthi we-multivitamin ohambisa isodium (SMVT): ekujolise kuko ekuhanjisweni kweziyobisi. Iithagethi zeziyobisi zeCurr 2012; 13: 994-1003. Jonga i-abstract.
  27. IPacheco-Alvarez D, iSolórzano-Vargas RS, iDel Río AL. I-Biotin kwiMetabolism kunye nokunxibelelana kwayo nezifo zoLuntu. IArch Med Res 2002; 33: 439-47. Jonga i-abstract.
  28. ISydenstricker, V. P., Singal, S. A., Briggs, A. P., Devaughn, N. M., kunye no-Isbell, H. Ukuqwalaselwa "kokulimala kweqanda elimhlophe" emntwini kunye nonyango lwayo nge-biotin concentrate. J NdinguMed Assn 1942;: 199-200.
  29. Ozand, PT, Gascon, GG, Al Essa, M., Joshi, S., Al Jishi, E., Bakheet, S., Al Watban, J., Al Kawi, MZ, kunye noDabbagh, O. Isiseko se-Biotin esiphendulayo. isifo se-ganglia: into yenoveli. Ubungqina 1998; 121 (Pt 7): 1267-1279. Jonga i-abstract.
  30. UWallace, J. C., Jitrapakdee, S., kunye noChapman-Smith, A. Pyruvate carboxylase. Int J Biochem.Cell Biol. Ngo-1998; 30: 1-5. Jonga i-abstract.
  31. I-Zempleni, J., Green, G. M., Spannagel, A. W., kunye ne-Mock, D. M. Biliary excretion ye-biotin kunye ne-biotin metabolites incinci kakhulu kwiigundane nakwiihagu. J Isondlo. Ngo-1997; 127: 1496-1500. Jonga i-abstract.
  32. UZempleni, J., McCormick, D.B, kunye noMock, D.M Ukuchongwa kwe-biotin sulfone, bisnorbiotin methyl ketone, kunye ne-tetranorbiotin-l-sulfoxide kumchamo womntu. Ndingu. J Kliniki. Ngo-1997; 65: 508-511. Jonga i-abstract.
  33. van der Knaap, M. S., Jakobs, C., kunye noValk, J. Imagnetic resonance imaging kwi-lactic acidosis. J Ilifa leMetab Dis. Ngo-1996; 19: 535-547. Jonga i-abstract.
  34. Shriver, B. J., Roman-Shriver, C., kunye noAllred, J. B. Ukupheliswa kunye nokuphindeka kwe-biotinyl enzymes kwisibindi seempuku ezingenanto ye-biotin: ubungqina benkqubo yokugcina i-biotin. J Isondlo. Ngo-1993; 123: 1140-1149.Jonga i-abstract.
  35. McMurray, D. N. Ukuzikhusela komzimba kwiseli yokunqongophala kwesondlo. Ukutya ukutya okuneNut. Sci. 1984; 8 (3-4): 193-228. Jonga i-abstract.
  36. Ammann, A. J. Ukuqonda okutsha koonobangela bokuphazamiseka komzimba. NdinguAcad. IDermatol. Ngo-1984; 11 (4 iPt 1): 653-660. Jonga i-abstract.
  37. UPetrelli, F., Moretti, P., kunye noPaparelli, M. Ukuhanjiswa kwe-Intracellular ye-biotin-14COOH kwisibindi se-rat. Umol. IBiol. 2-15-1979; 4: 247-252. Jonga i-abstract.
  38. UZlotkin, S.H, Stallings, V. A., kunye noPencharz, P. B. Iyonke isondlo sabazali kubantwana. I-Pediatr Clin. Emantla Am. Ngowe-1985; 32: 381-400. Jonga i-abstract.
  39. UBowman, B. B., Selhub, J., kunye noRosenberg, I. H. Ukufakwa kwamathumbu emathunjini e-biotin kumgangatho. J Isondlo. Ngo-1986; 116: 1266-1271. Jonga i-abstract.
  40. IMagnuson, N. S. kunye nePerryman, L. IComp Biochem. IPhysol B 1986; 83: 701-710. Jonga i-abstract.
  41. Nyhan, W. L. Iimpazamo zokuzalwa ze-biotin metabolism. IArch eDermatol. Ngo-1987; 123: 1696-1698a. Jonga i-abstract.
  42. USweetman, uL. NoNyhan, uW. L. Ukuphazamiseka okungafumanekiyo kunyango lwe-biotin kunye neziganeko ezinxulumene noko. ISityhi. Ngo-1986; 6: 317-343. Jonga i-abstract.
  43. Brenner, S. kunye noHorwitz, C. Abalamli abanokubakho bezondlo kwi-psoriasis kunye ne-seborrheic dermatitis. II. Abalamli bezondlo: ii-acid ezifanelekileyo; iivithamini A, E no-D; iivithamini B1, B2, B6, niacin kunye ne-biotin; ivithamini C selenium; zinc; intsimbi. Kwihlabathi uMfu uNutr. Ngo-1988; 55: 165-182. Jonga i-abstract.
  44. UMiller, S. J. Ukunqongophala kwesondlo kunye nolusu. NdinguAcad. IDermatol. Ngo-1989; 21: 1-30. Jonga i-abstract.
  45. UMichalski, A., Berry, G., Segal, S. Holocarboxylase synthetase defence: 9-iminyaka yokulandelwa kwesigulana kunyango lwe-biotin engapheliyo kunye nokuphononongwa koncwadi. J Ilifa leMetab Dis. Ngo-1989; 12: 312-316. Jonga i-abstract.
  46. IColombo, V. E., Gerber, F., Bronhofer, M., kunye neFloersheim, G. L. Unyango lweenzipho ezinobunzima kunye ne-onychoschizia nge-biotin: ukuskena i-electron microscopy. NdinguAcad. IDermatol. Ngo-1990; 23 (6 iPt 1): 1127-1132. Jonga i-abstract.
  47. UDaniells, S. kunye noHardy, G. Ukulahleka kweenwele kwithuba elide okanye ekhaya lokondla kwabazali: Ngaba ukusilela kwimicronutrient kusolwa? I-Curr.Opin.Clin.Nutr.Ukhathalelo lweMetab 2010; 13: 690-697. Jonga i-abstract.
  48. Ingcuka, B. Imiba yezonyango kunye nemibuzo rhoqo malunga nokusilela kwe-biotinidase. Umol. I-Metetet 2010, 100: 6-13. Jonga i-abstract.
  49. UZempleni, J., Hassan, Y.I, kunye neWijeratne, S. S. Biotin kunye nokusilela kwe-biotinidase. Ingcali. U-Rev. Endocrinol. IMetab 11-1-2008; 3: 715-724. Jonga i-abstract.
  50. Tsao, C.Y. Iindlela zangoku zonyango lwee-spasms zeentsana. Unyango lwe-Neuropsychiatr. Ngo-2009; 5: 289-299. Jonga i-abstract.
  51. Sedel, F., Lyon-Caen, O., kunye noSaudubray, J. M. [Unyango lwezifo ezinokuthanani nelifa]. UMfu Neurol. (Paris) 2007; 163: 884-896. Jonga i-abstract.
  52. Sydenstricker, V. P., Singal, S. A., Briggs, A. P., Devaughn, N. M., kunye no-Isbell, H. AMANQAKU OKUQALA OKUQHELEKILEYO KWI "EGG WHITE WHITE" EMNTWINI NONYANGO LWAYO NE-BIOTIN CONCENTRATE. Inzululwazi 2-13-1942; 95: 176-177. Jonga i-abstract.
  53. Scheinfeld, N., Dahdah, M. J., kunye noSher, R. Iivithamini kunye neeminerali: indima yabo kwimpilo yezipikili nakwizifo. J Iziyobisi iDermatol. Ngo-2007; 6: 782-787. Jonga i-abstract.
  54. Spector, R. kunye noJohanson, C. E. Uthutho lwevithamini kunye ne-homeostasis kwingqondo ye-mammalian: gxila kwiVithamini B kunye no-E J Neurochem. Ngo-2007; 103: 425-438. Jonga i-abstract.
  55. Ukuhlekisa, D. M. Ukubonakaliswa kolusu lokusilela kwe-biotin. Isidina sedermol. Ngo-1991; 10: 296-302. Jonga i-abstract.
  56. IBolander, F. F. Iivithamini: hayi i enzymes kuphela. I-Curr.Opin.Uphando.Iziyobisi 2006; 7: 912-915. Jonga i-abstract.
  57. I-Prasad, A. N. kunye neSeshia, S. S. Imeko yokuxhuzula kunyango lwabantwana: ulutsha olufikisayo. Umcebisi uNeurol. Ngo-2006; 97: 229-243. Jonga i-abstract.
  58. UWilson, CJ, Myer, M., Darlow, BA, Stanley, T., Thomson, G., Baumgartner, ER, Kirby, DM, kunye noThorburn, DR. . J Isilwanyana. Ngo-2005; 147: 115-118. Jonga i-abstract.
  59. Ukuhlekisa, D. M. Ukunqongophala kwe-biotin ye-biotin yi-teratogenic kwiimpuku kwaye mhlawumbi nabantu: uphononongo lokusilela kwe-biotin ngexesha lokukhulelwa komntu kunye nefuthe lokunqongophala kwe-biotin kwimbonakalo yemfuza kunye nemisebenzi ye-enzyme kwidama lempuku nakwimbungu. J Isondlo. Ngo-2005; 16: 435-437. Jonga i-abstract.
  60. UFernandez-Mejia, C. Iziphumo ze-Pharmacological ye-biotin. J Isondlo. 2005; 16: 424-427. Jonga i-abstract.
  61. UDakshinamurti, K. Biotin -umlawuli wentetho yemfuza. J Isondlo. Ngo-2005; 16: 419-423. Jonga i-abstract.
  62. Zeng, WQ, Al Yamani, E., Acierno, JS, Jr., Slaugenhaupt, S., Gillis, T., MacDonald, ME, Ozand, PT, kunye noGusella, JF Biotin-ephendula imephu yesifo se-basal ganglia kwi-2q36.3. kwaye kungenxa yotshintsho kwi-SLC19A3. Ndingu. J Hum. Uhlobo. 2005; 77: 16-26. Jonga i-abstract.
  63. IBaumgartner, M. R. Inkqubo yemolekyuli yokubonisa okubonakalayo kwi-3-methylcrotonyl-CoA carboxylase defence. J Ilifa leMetab Dis. Ngo-2005; 28: 301-309. Jonga i-abstract.
  64. I-Pacheco-Alvarez, D., Solorzano-Vargas, RS, Gravel, RA, Cervantes-Roldan, R., Velazquez, A., kunye noLeon-Del-Rio, A. Ummiselo ophikisayo wokusetyenziswa kwe-biotin kwingqondo nakwisibindi kunye nefuthe Ukusilela kwilifa le-carboxylase. J Biol Chem. 12-10-2004; 279: 52312-52318. Jonga i-abstract.
  65. I-Snodgrass, S. R. Vitamin neurotoxicity. Umzobo Neurobiol. Ngo-1992; 6: 41-73. Jonga i-abstract.
  66. ICampistol, J. [Ukudumba kunye neempawu zesifo sokuwa zosana olusandul 'ukuzalwa. Iifom zentetho, iinkqubo zokufunda kunye nonyango]. ISityhi Neurol. 10-1-2000; 31: 624-631. Jonga i-abstract.
  67. UNarisawa, K. [Imolekyuli yokuphendula ngokuzalwa iimpazamo kwimetabolism]. UNippon Rinsho 1999; 57: 2301-2306. Jonga i-abstract.
  68. UFurukawa, Y. [Ukuphuculwa kwe-insulin-ukukhutshwa kwe-insulin kunye nokuguqulwa kweswekile ye-glucose yi-biotin]. UNippon Rinsho 1999; 57: 2261-2269. Jonga i-abstract.
  69. UZempleni, J. kunye noMock, D. M. Uhlalutyo oluphambili lwe-biotin metabolites kulwelo lomzimba luvumela umlinganiso ochanekileyo ngakumbi we-biotin bioavailability kunye ne-metabolism ebantwini. J Isondlo. Ngo-1999; 129 (2S Suppl): 494S-497S. Jonga i-abstract.
  70. IiHymes, J. kunye neWolf, B. I-biotinidase yoluntu ayisiyokuphinda isetyenziswe kwakhona kwi-biotin. J Isondlo. Ngo-1999; 129 (2S Suppl): 485S-489S. Jonga i-abstract.
  71. UZempleni J, uMhlekazi we-DM. I-Biotin biochemistry kunye neemfuno zabantu. J Isondlo sebhayoloji. Ngo-1999 uMar; 10: 128-38. Jonga i-abstract.
  72. U-Eakin RE, u-Snell EE, kunye no-Williams RJ. Ukugxila kunye nokuvavanywa kwe-avidin, iiarhente ezivelisa ukwenzakala kumhlophe okweqanda. J Biol Chem. Ngo-1941;: 535-43.
  73. USpencer RP kunye noBrody KR. Ukuhanjiswa kweBiotin ngamathumbu amancinci erati, ihamster kunye nolunye uhlobo. NdinguJ Physiol. Ngo-1964 uMar; 206: 653-7. Jonga i-abstract.
  74. UZempleni J, Wijeratne SS, noHassan YI. Biotin. Izinto ezenziwayo. Ngo-2009 uJan-Feb; 35: 36-46. Jonga i-abstract.
  75. IGreen NM. I-Avidin. Ukusetyenziswa kwe-14-C) ye-biotin kwizifundo ze-kinetic kunye ne-assay. Indalo. UJ. 1963; 89: 585-591. Jonga i-abstract.
  76. URodriguez-Melendez R, uGriffin JB, uZempleni J.Ukuxhaswa kweBiotin kwandisa ukubonakaliswa kohlobo lwe-cytochrome P450 1B1 kwiiseli zeJurkat, ekonyusa ukwenzeka kwekhefu le-DNA elahlukileyo. J Isondlo. 2004 Sep; 134: 2222-8. Jonga i-abstract.
  77. Grundy WE, Khululwa M, Johnson HC, et al. Iziphumo ze-phthalylsulfathiazole (sulfathalidine) ekukhupheleni kweevithamini ze-B ngabantu abadala abaqhelekileyo. IArch Biochem. Ngo-1947 uNov; 15: 187-94. Jonga i-abstract.
  78. IRoth K.S. I-Biotin kunyango lwezonyango-uphononongo. NdinguJ oNyango lweeKlinikhi. 1981 Sep; 34: 1967-74. Jonga i-abstract.
  79. Fiume MZ. Iphaneli yeNgcali yeZithako zokuThambisa izithambiso. Ingxelo yokugqibela ngovavanyo lokhuseleko lwe-biotin. Int J Ityhefu. 2001; 20 Isihlomelo 4: 1-12. Jonga i-abstract.
  80. UGeohas J, uDaly A, uJuturu V, et al. I-Chromium picolinate kunye nokudityaniswa kwe-biotin kunciphisa isalathiso se-plasma ye-atherogenic kwizigulana ezinesifo seswekile sesifo seswekile: indawo elawulwa yi-placebo, eyimfama ephindwe kabini, yolingo olungenamkhethe. NdinguJ Med Sci. Ngo-2007 kuMar; 333: 145-53. Jonga i-abstract.
  81. I-Ebek, Inc. ikhupha ngokuzithandela ilizwe lonke ukukhumbula i-Liviro3, imveliso ethengiswa njengesongezelelo sokutya. Ukukhutshwa kwe-Ebek Press, ngoJanuwari 19, 2007. Iyafumaneka apha: http://www.fda.gov/oc/po/firmrecalls/ebek01_07.html.
  82. Umculi we-GM, uGeohas J. Iziphumo ze-chromium picolinate kunye ne-biotin yokuncedisa kulawulo lwe-glycemic kwizigulana ezilawulwa kakubi ezinesifo seswekile sesifo seswekile: isilingo esilawulwa yi-placebo, esingaboniyo, esingahleliwe. Iswekile Technol Ther 2006; 8: 636-43. Jonga i-abstract.
  83. URathman SC, uEisenschenk S, McMahon RJ. Ubuninzi kunye nokusebenza kwee-enzymes ezixhomekeke kwi-biotin ziyancitshiswa kwiigundane ezilawulwa ngokungapheliyo zi-carbamazepine. J Amanqatha 2002; 132: 3405-10. Jonga i-abstract.
  84. Ukuhlekisa nge-DM, iDyken ME. I-Biotin catabolism iyakhawuleziswa kubantu abadala abafumana unyango lwexesha elide kunye nee-anticonvulsants. Neurology 1997; 49: 1444-7. Jonga i-abstract.
  85. IAlbarracin C, uFuqua B, uEvans JL, isazisi seGoldfine. IChromium picolinate kunye nokudityaniswa kwe-biotin kuphucula i-glucose metabolism kunyango, ukungalawuleki ukutyeba kakhulu kwizigulana ezityebileyo ezine-2 yeswekile. Isifo seswekile iMetab Res Rev 2008; 24: 41-51. Jonga i-abstract.
  86. UGeohas J, uFinch M, uJuturu V, et al. Ukuphuculwa kokuzila ukutya kweGlucose yegazi ngokudityaniswa kweChromium Picolinate kunye neBiotin kuDidi 2 lweswekile iMellitus. I-American Diabetes Association ye-64 yeNtlanganiso yoNyaka, ngoJuni 2004, eOrlando, eFlorida, kwi-191-OKANYE.
  87. Ukuhlekisa nge-DM, iDyken ME. Ukusilela kweBiotin kubangelwa lonyango lwexesha elide kunye nee-anticonvulsants (ezingabonakaliyo). I-Gastroenterology 1995; 108: A740.
  88. IKrause KH, Berlit P, Bonjour JP. Isimo seVitamin kwizigulana kunyango olungapheliyo lwe-anticonvulsant. I-Int J Vitam Nutr Res ngo-1982; 52: 375-85. Jonga i-abstract.
  89. UKrause KH, uKochen W, uBerlit P, uBonjour JP. Ukuchithwa kwee-acid ze-organic ezinxulunyaniswa nokusilela kwe-biotin kunyango lwe-anticonvulsant engapheliyo. I-Int J Vitam Nutr Res ngo-1984; 54: 217-22. Jonga i-abstract.
  90. I-Sealey WM, i-AM engaziwayo, iStratton SL, iMock DM. Ukutshaya kukhawulezisa i-biotin catabolism kwabasetyhini. NdinguJ J Clin Nutriti 2004; 80: 932-5. Jonga i-abstract.
  91. Ukuhlekisa nge-NI, iMalik MI, iStumbo PJ, et al. Ukonyuka kokukhutshwa komchamo kwe-3-hydroxyisovaleric acid kunye nokuhla kokukhutshwa komchamo we-biotin ziimpawu ezibuthathaka zokuqala kwimo yokuncipha kovavanyo lwe-biotin. NdinguJ J Clin Nutr 1997; 65: 951-8. Jonga i-abstract.
  92. UBaez-Saldana A, uZendejas-Ruiz I, u-Revilla-Monsalve C, et al. Iziphumo ze-biotin kwi-pyruvate carboxylase, i-acetyl-CoA carboxylase, i-propionyl-CoA carboxylase, kunye neempawu zeswekile kunye ne-lipid homeostasis kuhlobo lwe-2 lwezigulana zeswekile kunye nezifundo ze-nondiabetic. NdinguJ J Clin Nutriti 2004; 79: 238-43. Jonga i-abstract.
  93. UZempleni J, uMhlekazi we-DM. Bioavailability of biotin enikwe ngomlomo ebantwini kwiidosi ze-pharmacologic. NdinguJ J Clin Nutriti 1999; 69: 504-8. Jonga i-abstract.
  94. Utshilo uHM. I-Biotin: ivithamini elityelweyo. NdinguJ oNyango lweeKlinikhi. 2002; 75: 179-80. Jonga i-abstract.
  95. UKeipert JA. Ukusetyenziswa komlomo kwe-biotin kwi-seborrhoeic dermatitis ebusaneni: ityala elilawulwayo. NguMed J Aust 1976; 1: 584-5. Jonga i-abstract.
  96. I-Koutsikos D, iAgroyannis B, iTzanatos-Exarchou H.I-Biotin yesifo seswekile seswekile. I-Biomed Pharmacother 1990; 44: 511-4. Jonga i-abstract.
  97. UCoggeshall JC, uHeggers JP, uRobson MC, et al. Isimo seBiotin kunye neplasma glucose kwizifo seswekile. UAnn N Y Acad Sci 1985; 447: 389-92.
  98. UZempleni J, Helm RM, DM ehlekisayo. Kwi vivo ukongezwa kwe-biotin kwidosi ye-pharmacologic kunciphisa ukukhula kwamanqanaba eepheripheral zegazi zeseli kunye ne-cytokine release. J Utyango 2001; 131: 1479-84. Jonga i-abstract.
  99. Ukuhlekisa nge-DM, i-Quirk JG, kunye ne-Mock NI. Ukusilela kwe-biotin ngexesha lokukhulelwa kwesiqhelo. NdinguJ J Clin Nutrit 2002; 75: 295-9. Jonga i-abstract.
  100. ICamacho FM, uGarcia-Hernandez MJ. I-Zinc aspartate, biotin, kunye ne-clobetasol propionate kunyango lwe-alopecia areata ebuntwaneni. Isidumbu seDermatol 1999; 16: 336-8. Jonga i-abstract.
  101. Ukutya kunye neBhodi yeZondlo, iZiko lezeMpilo. Ukufakwa kwereferensi yokutya kwi-Thiamin, i-Riboflavin, i-Niacin, i-Vitamin B6, i-Folate, i-Vitamin B12, i-Pantothenic Acid, i-Biotin kunye ne-Choline. IWashington, DC: ICandelo leSizwe lezeMfundo, 2000. Iyafumaneka kwi: http://books.nap.edu/books/0309065542/html/.
  102. I-Hill MJ. Iintyatyambo zamathumbu kunye ne-vitamin endo native synthesis. I-Eur J Cancer ngaphambili 1997; 6: S43-5. Jonga i-abstract.
  103. Inkulumbuso ye-Debourdeau, i-Djezzar S, i-Estival JL, et al. Ubungozi be-eosinophilic pleuropericardial effusion ehambelana neevithamini B5 kunye noH. Ann Pharmacother 2001; 35: 424-6. Jonga i-abstract.
  104. Shils ME, Olson JA, Shike M, Ross AC, ii-eds. Isondlo sangoku kwezempilo nakwizifo. Umhla we-9. IBaltimore, MD: UWilliams kunye noWilkins, ngo-1999.
  105. ILininger SW. Ikhemesti yeNdalo. Umhla woku-1. I-Rocklin, CA: Ukupapashwa kwePrima; Ngo-1998.
  106. Ukuhlekisa nge-DM, ukuhlekisa nge-NI, uNelson RP, uLombard KA. Ukuphazamiseka kwimetabolism ye-biotin ebantwaneni abanyangwa ixesha elide yonyango lwe-anticonvulsant. J Isidlangalala seGastroentereol Nutriti 1998; 26: 245-50. Jonga i-abstract.
  107. I-Krause KH, i-Bonjour JP, i-Berlit P, i-Kochen W.I-Biotin inqanaba lokuxhuzula. UAnn N Y Acad Sci 1985; 447: 297-313. Jonga i-abstract.
  108. Bonjour JP. I-Biotin kwisondlo sabantu. UAnn N Y Acad Sci 1985; 447: 97-104. Jonga i-abstract.
  109. Utshilo u-HM, u-Redha R, u-Nylander W. Uthutho lwe-Biotin emathunjini omntu: inhibition yeziyobisi ze-anticonvulsant. NdinguJ J Clin Nutriti 1989; 49: 127-31. Jonga i-abstract.
  110. IHochman LG, iSherher RK, iMeyerson MS. Izikhonkwane ezaphukileyo: impendulo kukongezwa kwe-biotin yemihla ngemihla. I-Cutis 1993; 51: 303-5. Jonga i-abstract.
  111. UHenry JG, uSobki S, Afafat N. Ungenelelo ngonyango lwe-biotin kwimilinganiselo ye-TSH kunye ne-FT4 nge-enzyme immunoassay kwi-Boehringer Mannheim ES 700 analyzer. U-Ann Clin Biochem 1996; 33: 162-3. Jonga i-abstract.
Ukuhlaziywa okokugqibela-12/11/2020

Ithandwa Kwisayithi

Zingaphi iikhalori kwiNkukhu? Isifuba, isinqe, iphiko kunye nokunye
Isondlo

Zingaphi iikhalori kwiNkukhu? Isifuba, isinqe, iphiko kunye nokunye

Inkukhu lukhetho oludumileyo xa kuziwa kwiprotein ecekeceke, njengoko ipaki ha i ixa e ikhulu kwindawo enye yokukhonza ngaphandle kwamafutha amaninzi.Kwaye kulula ukupheka ekhaya kwaye kufumaneka kwii...
Yintoni Ebangela Intlungu Yam Yovalo kwaye Ndingayinyanga Njani?
Zempilo

Yintoni Ebangela Intlungu Yam Yovalo kwaye Ndingayinyanga Njani?

U hwankatheloI-diaphragm i ihlunu e ime njenge-mu hroom e ihlala phant i kwembambo yakho e ezant i ukuya embindini. Ikwahlula i i u akho kwindawo yakho ye-thoracic.I-diaphragm yakho ikunceda uphefuml...